A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics and dosage of EPB-348 that
best balances safety and efficacy among adult immunocompetent patients with an acute episode
of herpes zoster.